As outpatient surgery accelerates worldwide, ambulatory surgical centres are emerging as a cornerstone of healthcare transformation – creating new opportunities for organisations that can improve efficiency, care coordination, and patient outcomes across the surgical journey
By Paljit Sohal, Vice President, Healthcare & Life Sciences, Frost & Sullivan
Healthcare delivery is undergoing one of its most significant structural shifts in decades, with ambulatory surgical centres (ASCs) evolving from a source of peripheral capacity relief to a core pillar of future healthcare infrastructure.
Frost & Sullivan analysis indicates that the global ASC market is forecast to grow by more than 30% between 2024 and 2029, driven by rising demand for efficient, cost-effective, and patient-centric care.
For organisations serving this market—whether through patient monitoring, medical devices, digital health solutions, software, or clinical services—the strategic implication is clear: ASC growth will reward companies that solve operational challenges, not simply those that supply clinical technology. Success will increasingly depend on understanding the clinical, operational, and economic pressures shaping outpatient surgical care.
While the term Ambulatory Surgical Centre (ASC) is most commonly used in the United States, comparable care settings exist across global healthcare markets under a range of different names and operating models. These include outpatient surgery centres, day surgery units, ambulatory care centres, ambulatory operating centres (AOPs), and specialist outpatient clinics. Ownership structures also vary widely, spanning physician-owned facilities, hospital-affiliated centres, corporate networks, and private healthcare providers.
Despite these differences, the direction of travel is clear: a growing share of surgical procedures is shifting from traditional inpatient hospitals into outpatient care settings.
Why ASCs Have Become a Strategic Priority
The growth of ASCs extends well beyond simple cost reduction.
Healthcare systems globally are under increasing pressure to improve access, reduce waiting times, expand procedural capacity, and deliver high-quality outcomes while managing limited financial and workforce resources. ASCs offer a compelling solution by enabling procedures to be performed in lower-cost, highly efficient environments without compromising quality.
The momentum behind ASC growth is being reinforced by a rare alignment of stakeholders. Providers are seeking greater efficiency and capacity, payers are looking to reduce healthcare expenditure, policymakers are attempting to address growing surgical backlogs, and patients increasingly prefer convenient, same-day care closer to home.
This alignment is translating into tangible policy action. In the United States, CMS recently expanded the ASC-covered procedures list by more than 570 procedures, creating additional incentives for providers to shift appropriate procedures into outpatient settings. Across Europe, governments are promoting day-case surgery through reimbursement reforms and dedicated outpatient initiatives designed to reduce pressure on acute hospitals.
Advances in minimally invasive surgery, anaesthesia, and perioperative care are further accelerating this transition by enabling increasingly complex procedures to be performed safely outside traditional hospital environments.
As a result, ASCs are becoming a strategic enabler of healthcare system transformation.
Operational Complexity Is Rising for ASC Operators
While procedural volumes continue to grow, ASC operators face increasing operational complexity.
Historically, many ASCs focused on relatively routine, low-acuity procedures. Today, however, a growing number are expanding into specialties such as orthopaedics, cardiovascular interventions, spine, gastroenterology, and other higher-acuity service lines. These procedures create new demands on staffing, patient monitoring, workflow management, and perioperative care.
At the same time, workforce shortages continue to affect perioperative nurses, anaesthesia teams, and clinical support staff. Operators are under pressure to maximise operating room utilisation, accelerate patient throughput, reduce recovery times, and support same-day discharge while maintaining high standards of patient safety.
Efficiency has therefore become more than an operating metric; it is now central to ASC competitiveness.
Every delay in patient flow, discharge, staffing, or equipment availability directly impacts revenue, patient experience, and capacity. As procedural complexity increases, ASC operators have less tolerance for solutions that add friction to clinical or administrative workflows.
Consequently, ASC leaders are evaluating investments through a broader lens. Purchasing decisions are no longer based solely on clinical performance or upfront capital costs. Increasingly, they are assessed based on their ability to improve workflow efficiency, reduce operational risk, support staff productivity, and contribute to long-term growth.
How Leading Organisations Are Responding
Leading ASC operators are responding by prioritising technologies and operating models that create measurable improvements in visibility, care co-ordination, and resource productivity.
Digital workflows are streamlining patient scheduling, documentation, and care co-ordination, while automation is reducing administrative burden and helping scarce clinical resources work more effectively. Integrated technologies are also improving visibility across the patient journey, enabling providers to manage higher procedural volumes with greater consistency.
Patient monitoring is also becoming increasingly important.
As procedural acuity increases, providers require greater visibility into patient status before, during, and after procedures. Monitoring technologies are evolving from standalone devices into connected solutions that support perioperative decision-making, recovery management, and post-discharge oversight.
The definition of value is also shifting.
Historically, purchasing decisions often centred on device specifications, performance characteristics, and capital acquisition costs. Today, providers are increasingly focused on broader operational and clinical outcomes:
- Improved patient throughput
- Reduced operational complexity
- Faster recovery and discharge
- Enhanced patient safety
- Greater workforce productivity
- Lower total cost of ownership
- Improved care continuity
This evolution is reshaping how vendors engage with customers and how growth opportunities are assessed.
How Companies Serving the Market Can Create More Value
For commercial, product, R&D, and customer-facing teams, the priority is to move from selling features to proving measurable impact against the outcomes ASC operators are trying to achieve.
Move Beyond Product Performance
Clinical performance remains essential, but executive buyers increasingly expect it to be linked to operational and economic value.
ASC operators are asking a different set of questions:
- How will this solution improve throughput?
- How will it reduce operational burden?
- How will it help us support higher-acuity procedures?
- How will it improve staff productivity?
Organisations that can clearly demonstrate these outcomes are likely to create stronger differentiation than those focused solely on technical specifications.
Understand the Economics of Outpatient Care
The ASC business model is fundamentally driven by efficiency.
Solutions that reduce patient delays, streamline workflows, improve room turnover, or support faster discharge may create greater value than those offering incremental technical improvements alone.
Commercial teams that understand these operational dynamics can elevate customer conversations from procurement discussions to strategic growth dialogues.
Design Around Workflows, Not Devices
ASC operators do not experience challenges in isolated clinical moments. They experience them across the entire patient journey.
Product and R&D teams should therefore look beyond individual devices and consider how technologies fit into broader outpatient workflows—from patient admission and procedure preparation through recovery and discharge.
The greatest opportunities often emerge where clinical, operational, and digital workflows intersect.
Leverage Data, Connectivity, and Services
As care delivery becomes increasingly connected, data-driven services will become an important source of differentiation.
Remote monitoring, predictive analytics, workflow insights, interoperability, training services, and clinical decision support capabilities all have the potential to create value beyond the device itself.
For vendors, these capabilities also provide opportunities to build longer-term customer relationships and transition from transactional equipment sales toward strategic partnerships.
Looking Ahead
The ASC market is entering a period of sustained expansion, supported by powerful structural, economic, and policy tailwinds.
Frost & Sullivan identifies ambulatory surgeries as one of the most significant growth opportunities in the medical devices industry, alongside AI-enabled monitoring devices, clinical insights services, and chronic disease management pathways.
For companies serving this market, the opportunity extends far beyond supplying products. The winners will be those that help providers deliver safer, more efficient, and more connected care across the entire outpatient surgical journey.
Organisations that align their portfolios, commercial strategies, and innovation roadmaps with these priorities will be best positioned to capture growth as ASCs redefine the future of healthcare delivery.
This article is the first instalment in a three-part Frost & Sullivan blog series examining the evolving ASC landscape.
